A perspective on B cell–targeted therapies in autoimmune disease
Search results for: Biologics
Sex Differences & Rheumatoid Arthritis
The beliefs versus the data
H1N1 Influenza A Virus Brings Many Questions, Few Answers
Rheumatologists grapple with vaccine concerns and the impact of medications on response
Practical Medication Management
Take a firm stand in perioperative and pregnant patients with rheumatic disease
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Annual Meeting Opportunities for Pediatric Rheumatologists
The ACR/ARHP Annual Scientific Meeting is the premier event for specialists in the field of rheumatology, and this year’s planning committee is committed to providing attendees with educational opportunities specifically tailored to their areas of interest.
From Paper to Practice
Using ACR RA recommendations to improve quality of care
Drug Updates
Information on safety, labeling changes, and pharmaceutical research
Healthcare in the Obama Administration
The ballots are counted, the run-off elections are complete, and a new administration and Congress are set to begin. You may recall that the mock election that was held during the 2008 Annual Scientific Meeting—78% of U.S. meeting attendees chose Barack Obama as their next president—and the general election echoed that choice. On January 20, Barack Obama was sworn in as the United States’ 44th President.
Measuring Quality of Care Is Here to Stay—and the ACR Can Help
Imagine a patient comes into your office with active RA or lupus. You diagnose her and prescribe medications for her active disease—rash, arthritis, and so forth—but you do nothing to address possible long-term complications. You don’t prescribe calcium or vitamin D to prevent osteoporosis, you don’t get a bone density scan, and you don’t order labs to check risk factors for heart disease.
- « Previous Page
- 1
- …
- 72
- 73
- 74
- 75
- 76
- 77
- Next Page »